Navigation Links
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Date:11/28/2007

EMERYVILLE, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc (NTI (TM)) (Nasdaq: NTII) announced today that Warren Wasiewski, M.D. was appointed Chief Medical Officer, effective as of November 26, 2007.

Dr. Wasiewski joined NTI in February 2007 as Vice President, Clinical Programs with primary responsibility for running the clinical trial program for Viprinex(TM), NTI's drug candidate for acute ischemic stroke that is currently in two Phase 3 clinical trials. Dr. Wasiewski is a Board Certified Pediatric Neurologist with an extensive clinical career. Prior to joining NTI, he worked at AstraZeneca where he was Sr. Medical Director of clinical research CNS/Emerging Products. At AstraZeneca, Dr. Wasiewski had responsibility for running the global SAINT trials for AstraZeneca's neuroprotectant drug candidate.

Dr. Wasiewski holds a Bachelor of Arts degree in Biology Cum Laude from Rutgers College, a Masters of Science degree in Biochemistry from State University of New York Downstate Medical Center, and a Doctorate of Medicine from State University of New York, at Buffalo.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The Company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
2. Governor Rendell Launches Tour to Insure in Warren County; Urges Passage of Plan to Give Access to Affordable Health Insurance
3. Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma
4. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
5. William Moore Appointed to IRIDEX Board of Directors
6. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
7. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
8. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
9. James B. Hawkins Appointed to IRIDEX Board of Directors
10. Bryan R. Rogers Appointed President of Far West Division
11. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... Using the power ... utilizing a simple online checklist. Over a period of just 24 months, thousands of ... of an online checklist called T.A.D. , “The internet is not getting quieter. In ...
(Date:2/22/2017)... Addison, TX (PRWEB) , ... February 22, 2017 ... ... announced the launch of ProGen™ PRP, the latest innovation in the delivery of ... orthopedics, wound care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the Athens Home Show ... Georgia. , A shift from Super-Sod’s simple Athens Home Show booth of 2016, this ... grass seed plant manager Chris Roquemore constructed furniture from recycled pallet wood at the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... threats. Yet with so many different solutions on the market, it is easy ... choices, Texas Premier Locksmith offers a complimentary security consultation. , Home ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has a ... every household and family to know all about it for optimal health. Wanting to ... release of “ Detox, Digestive and Wellness Solutions ” (published by Balboa Press AU). ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017  CVS Pharmacy is the first national retail ... oils (PHO), the primary source of artificial trans fats ... food products. The retailer now offers over 600 exclusive ... trans fats. This comes a year and a half ahead ... 2018 for processed foods to be reformulated without artificial ...
(Date:2/22/2017)... Des scanners sur smartphone destinés aux professionnels de ... , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , une société de santé numérique ... Canada , a annoncé aujourd,hui qu,elle a reçu la ... Clarius C3 et L7, destinés à être utilisés par des professionnels de ...
(Date:2/22/2017)... LUND, Sweden , Feb 22, 2017 ... the mitochondrial medicine company, today announced two new research ... , PhD, and Professor Massimo Pinzani , MD, ... agreements is to further explore NeuroVive,s new drug compounds ... carcinoma (HCC). In the new collaboration ...
Breaking Medicine Technology: